Stephen Aronoff

4.9k total citations · 1 hit paper
21 papers, 1.9k citations indexed

About

Stephen Aronoff is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Stephen Aronoff has authored 21 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Endocrinology, Diabetes and Metabolism, 7 papers in Surgery and 6 papers in Molecular Biology. Recurrent topics in Stephen Aronoff's work include Diabetes Management and Research (14 papers), Diabetes Treatment and Management (12 papers) and Pancreatic function and diabetes (6 papers). Stephen Aronoff is often cited by papers focused on Diabetes Management and Research (14 papers), Diabetes Treatment and Management (12 papers) and Pancreatic function and diabetes (6 papers). Stephen Aronoff collaborates with scholars based in United States, Sweden and Canada. Stephen Aronoff's co-authors include Kathy J. Berkowitz, Laura L. Want, W. Kline Bolton, Sally A. Hood, K. Linda Tang, Brian Wasserman, Thomas F. Tse, William McClellan, Daniel L. Lorber and Peter H. Bennett and has published in prestigious journals such as The Lancet, Annals of Internal Medicine and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Stephen Aronoff

20 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Continuous Glucose Monitoring Versus Usual Care in Patients With Type 2 Diabetes Receiving Multiple Daily Insulin Injections

2017 449 citations Roy W. Beck, Tonya D. Riddlesworth et al. Annals of Internal Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Stephen Aronoff United States	13	1.2k	743	656	293	262	21	1.9k
Chris Tikellis Australia	27	622 0.5×	287 0.4×	145 0.2×	763 2.6×	62 0.2×	41	2.5k
Cijiang He United States	22	928 0.8×	98 0.1×	101 0.2×	251 0.9×	191 0.7×	30	2.3k
Matthew J. Sheetz United States	17	406 0.3×	179 0.2×	106 0.2×	541 1.8×	69 0.3×	24	1.9k
Aldi T. Kraja United States	28	380 0.3×	166 0.2×	592 0.9×	619 2.1×	106 0.4×	69	1.8k
Mary Donoghue United States	5	987 0.8×	370 0.5×	114 0.2×	664 2.3×	31 0.1×	5	2.9k
Hiroshi Kajio Japan	25	1.0k 0.9×	753 1.0×	557 0.8×	575 2.0×	21 0.1×	140	2.5k
Shoji Kawazu Japan	25	870 0.7×	889 1.2×	419 0.6×	618 2.1×	26 0.1×	89	1.9k
Moshe Weintraub Israel	22	841 0.7×	853 1.1×	93 0.1×	281 1.0×	53 0.2×	43	2.1k
Xiao‐Mei Li China	25	345 0.3×	485 0.7×	126 0.2×	446 1.5×	53 0.2×	165	2.0k
Paola Massucco Italy	24	696 0.6×	172 0.2×	92 0.1×	277 0.9×	123 0.5×	63	1.8k

Countries citing papers authored by Stephen Aronoff

Since Specialization

Citations

This map shows the geographic impact of Stephen Aronoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen Aronoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen Aronoff more than expected).

Fields of papers citing papers by Stephen Aronoff

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen Aronoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen Aronoff. The network helps show where Stephen Aronoff may publish in the future.

Co-authorship network of co-authors of Stephen Aronoff

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen Aronoff. A scholar is included among the top collaborators of Stephen Aronoff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen Aronoff. Stephen Aronoff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Burger, Judith A., et al.. (2025). Newborn RSV immunization rates and reasons compared to family COVID-19 and influenza immunization status. BMC Pediatrics. 25(1). 555–555. 1 indexed citations

Aronoff, Stephen, et al.. (2024). Variability in the Evaluation and Treatment of Healthy Neonates With Uncomplicated Conjunctivitis. Journal of Pediatric Ophthalmology & Strabismus. 62(2). 143–149.

Beck, Roy W., Tonya D. Riddlesworth, Katrina J. Ruedy, et al.. (2017). Continuous Glucose Monitoring Versus Usual Care in Patients With Type 2 Diabetes Receiving Multiple Daily Insulin Injections. Annals of Internal Medicine. 167(6). 365–374. 449 indexed citations breakdown →

Aronoff, Stephen. (2017). Rationale for treatment options for mealtime glucose control in patients with type 2 diabetes. Postgraduate Medicine. 129(2). 231–241. 8 indexed citations

Schmeltz, Lowell R., Thomas Blevins, Stephen Aronoff, et al.. (2013). Anatabine Supplementation Decreases Thyroglobulin Antibodies in Patients With Chronic Lymphocytic Autoimmune (Hashimoto's) Thyroiditis: A Randomized Controlled Clinical Trial. The Journal of Clinical Endocrinology & Metabolism. 99(1). E137–E142. 17 indexed citations

Sherry, Nicole, William Hagopian, Johnny Ludvigsson, et al.. (2011). Teplizumab for treatment of type 1 diabetes (Protégé study): 1-year results from a randomised, placebo-controlled trial. The Lancet. 378(9790). 487–497. 363 indexed citations

Blevins, Thomas, et al.. (2010). Exenatide is Non-inferior to Insulin in Reducing HbA _1c : An Integrated Analysis of 1423 Patients with Type 2 Diabetes. Postgraduate Medicine. 122(3). 118–128. 18 indexed citations

Lloyd, Andrew, Paul Swinburn, Kristina S. Boye, et al.. (2010). A Valuation of Infusion Therapy to Preserve Islet Function in Type 1 Diabetes. Value in Health. 13(5). 636–642. 5 indexed citations

Blevins, Thomas, Sherwyn Schwartz, Bruce W. Bode, et al.. (2008). A Study Assessing an Injection Port for Administration of Insulin. Diabetes Spectrum. 21(3). 197–202. 3 indexed citations

10.

Kruger, Davida, Stephen Aronoff, & Steven V. Edelman. (2007). Through the Looking Glass. The Diabetes Educator. 33(2_suppl). 32S–46S. 4 indexed citations

11.

McClellan, William, Stephen Aronoff, W. Kline Bolton, et al.. (2004). The prevalence of anemia in patients with chronic kidney disease. Current Medical Research and Opinion. 20(9). 1501–1510. 348 indexed citations

12.

Aronoff, Stephen, et al.. (2004). Glucose Metabolism and Regulation: Beyond Insulin and Glucagon. Diabetes Spectrum. 17(3). 183–190. 392 indexed citations

13.

Aronoff, Stephen, et al.. (2000). Pioglitazone Hydrochloride Monotherapy Improves Glycemic Control in the Treatment of Patients With Type 2 Diabetes. 43 indexed citations

14.

Hidaka, Hideki, M. Nagulesparan, I Klimeś, et al.. (1982). Improvement of Insulin Secretion but Not Insulin Resistance after Short Term Control of Plasma Glucose in Obese Type II Diabetics*. The Journal of Clinical Endocrinology & Metabolism. 54(2). 217–222. 88 indexed citations

15.

Aronoff, Stephen, et al.. (1981). Urinary Excretion and Renal Clearance of Specific Plasma Proteins in Diabetes of Short and Long Duration. Diabetes. 30(8). 656–663. 23 indexed citations

16.

Aronoff, Stephen, et al.. (1980). Norepinephrine and epinephrine secretion from a clinically epinephrine-secreting pheochromocytoma. The American Journal of Medicine. 69(2). 321–324. 41 indexed citations

17.

Gingerich, Ronald L., Stephen Aronoff, David Kipnis, & Paul E. Lacy. (1979). Insulin and Glucagon Secretion from Rat Islets Maintained in a Tissue Culture-Perifusion System. Diabetes. 28(4). 276–281. 12 indexed citations

18.

Aronoff, Stephen, Peter H. Bennett, & Roger H. Unger. (1977). Immunoreactive Glucagon (IRG) Responses to Intravenous Glucose in Prediabetes and Diabetes Among Pima Indians and Normal Caucasians. The Journal of Clinical Endocrinology & Metabolism. 44(5). 968–972. 28 indexed citations

19.

Aronoff, Stephen, Peter H. Bennett, Norman B. Rushforth, Max Miller, & Roger H. Unger. (1976). Arginine-Stimulated Hyperglucagonemia in Diabetic Pima Indians. Diabetes. 25(5). 404–407. 21 indexed citations

20.

Bennett, Peter H., Stephen Aronoff, & Roger H. Unger. (1976). Evidence for an insulin-independent alpha-cell abnormality in human diabetes. Metabolism. 25(11). 1527–1529. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact